Core Viewpoint - The Hong Kong pharmaceutical ETF (159718) experienced a decline of 2.82% on October 17, with a trading volume of 50.7552 million yuan, indicating a downward trend in the market [1] Group 1: ETF Performance - The ETF's shares decreased by 1 million, bringing the total to 223 million shares, with a reduction of 20 million shares over the last 20 trading days [1] - The latest net asset value is calculated at 220 million yuan [1] - Since its establishment on December 16, 2021, the ETF has returned -1.24%, with a one-month return of -9.39% [1] Group 2: Management and Benchmark - The ETF's performance benchmark is the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index (adjusted for exchange rates) [1] - The fund is managed by Ping An Fund Management Co., Ltd., with the fund manager being Weng Xin [1]
10月17日港股医药ETF（159718）份额减少100.00万份
Xin Lang Cai Jing·2025-10-20 01:08